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Associations of childhood
25-hydroxyvitamin D2 and D3 and
cardiovascular risk factors in adolescence:
prospective findings from the Avon
Longitudinal Study of Parents and
Children
Dylan M Williams1, Abigail Fraser1, Adrian Sayers2,
William D Fraser3, Elina Hyppo¨nen4, George Davey Smith1,
Naveed Sattar5 and Debbie A Lawlor1
Abstract
Background: Studies of the associations of circulating total 25-hydroxyvitamin D (25(OH)D) with cardiovascular
disease risk factors in adults have reported inconsistent findings. We aimed to compare prospective associations of
two analogues of childhood 25(OH)D (25(OH)D2 and 25(OH)D3) with cardiovascular risk factors measured in
adolescence.
Methods and results: We examined associations of childhood (ages 7–12 years) 25(OH)D2 and 25-25(OH)D3 with a
range of cardiovascular risk factors (blood pressure, fasting lipids, glucose, insulin and C-reactive protein (CRP))
determined in adolescence (mean age 15.4 years). Data were from 2470 participants of the Avon Longitudinal Study
of Parents and Children (ALSPAC), a prospective population-based cohort. After adjustments for age, gender, socio-
economic position and BMI, there were no associations of 25(OH)D2 with cardiovascular risk factors. There was a
positive association of season-adjusted (and unadjusted) 25(OH)D3 with high-density lipoprotein cholesterol (HDL-C)
(mean change per doubling of 25(OH)D3: 0.03 mmol/l; 95% confidence interval (CI): 0.001 to 0.05, p¼ 0.02) and an
inverse association with fasting insulin (relative difference of 4.59% per doubling; 95% CI: 8.37 to 0.59, p¼ 0.03).
Participants with total 25(OH)D concentration <50 nmol/l had 0.04 mmol/l lower HDL-C (95% CI: 0.07 to 0.01) and
5.54% higher fasting insulin (95% CI: 0.82 to 10.47) compared with participants with total 25(OH)D 72 nmol/l.
Conclusions: In the first prospective study of children/adolescents, we have shown that higher 25(OH)D3 concentra-
tions in childhood are associated with higher levels of HDL-C and lower fasting insulin in adolescence.
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Introduction
Several studies have reported inverse associations of
circulating total 25-hydroxyvitamin D (25(OH)D) and
cardiovascular disease incidence, mortality and levels of
cardiovascular risk factors in adult populations.1–3
Whilst the associations of total 25(OH)D with cardio-
vascular risk factors have been studied cross-sectionally
in adolescence, with inconsistent ﬁndings,4–8 prospect-
ive studies are lacking.
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Recently, a need to distinguish between the two ana-
logues of circulating 25(OH)D has been recognised.9
Despite recommendations suggesting 25(OH)D deﬁ-
cient patients can be treated with supplementation by
either vitamin D2 or D3,
10 a recent meta-analysis found
vitamin D3, but not D2, supplementation to decrease
all-cause mortality.11 25(OH)D2 and D3 have diﬀering
potencies in their eﬀects on bone metabolism,9 but it is
unclear whether the diﬀerence in molar potency trans-
lates to diﬀerences in strengths of associations with car-
diovascular risk factors. Previous randomised
controlled trials have been criticised on the basis that
dosages or supplement type may not have been suﬃ-
cient to give meaningful increases in 25(OH)D status.12
Thus, it is necessary to establish whether 25(OH)D2
and 25(OH)D3 status are diﬀerentially associated with
cardiovascular risk factors. Recently, we conducted a
cross-sectional study in children (mean age 9.9 years)
and found some evidence of diﬀerences in associations
of 25(OH)D2 and 25(OH)D3 with cardiovascular risk
factors.13 We were unable to explore associations with
fasting glucose and insulin, which have been related to
25(OH)D concentrations in adults,2,14 and prospective
studies in this area are important for examining associ-
ations with less possibility that these may have resulted
from reverse causality.
Our aim here is to build on that work by estimating
and comparing prospective associations of 25(OH)D2
and 25(OH)D3 measured in childhood with a range of
cardiovascular risk factors (blood pressure, fasting
lipids, insulin, glucose and C-reactive protein (CRP))




The Avon Longitudinal Study of Parents and Children
(ALSPAC) is a prospective birth cohort that recruited
pregnant women (n¼ 14,541) in the former county of
Avon, South West England. Women with an expected
delivery date between 1 April 1991 and 31 December
1992 were eligible to be included. Full details of the
study have been published15,16 and are found online
at http://www.alspac.bris.ac.uk. Live born children
(n¼ 13,972) who survived past age one year have
been followed up alongside their mothers with ques-
tionnaires during early childhood, and at regular
assessments from age seven years. Ethical approval
was granted by the ALSPAC Law and Ethics commit-
tee and the local research ethics committee, in compli-
ance with the Declaration of Helsinki. Written
informed consent/assent was obtained from both
parents/guardians and the children. For this study, we
used measures of 25(OH)D from blood samples col-
lected from children at the follow-up assessments at
seven, nine or 11 years, and cardiovascular risk factors
measured when the children attended the year 15
follow-up assessment (mean follow-up: 5.5 years).
A total of 2470 children had valid 25(OH)D measures,
attended the year 15 assessment and had complete
information on exposures, outcomes and co-variables,
and these form our main study sample (see
Supplementary Figure 1).
Measures
For most participants 25(OH)D2 and 25(OH)D3 were
measured on non-fasting blood samples taken during
the year 9 assessments (n¼ 1965). When samples from
this age were not available we used measures sampled
from year 11 (n¼ 406) or year 7 (n¼ 99) assessments.
Details of 25(OH)D, PTH, calcium and phosphate
assays, as well as measurements of outcomes and
co-variables, are included in the Supplementary
Material.
Statistical analysis
25(OH)D2 and 25(OH)D3 were loge transformed to
reduce heteroscedasticity. 25(OH)D3 was adjusted for
seasonal variability, as previously described.13 In order
to include all children on whom 25(OH)D2 was
assayed, those with a value below the detectable limit
of the assay (1.25 nmol/l) (34.5%) were assigned a value
of 1.25 nmol/l. Children with 25(OH)D2 at or below the
detection limit were also indicated using a binary vari-
able (i.e. 0¼measured 25(OH)D2 value; 1¼ a value at
or below the detection limit) in all association regres-
sion models of 25(OH)D2 with cardiovascular risk
factors.
Multivariable linear regression models were used to
examine the associations of 25(OH)D2 and season-
adjusted 25(OH)D3 with cardiovascular risk factors
and to adjust for potential confounding and mediating
factors. Regression coeﬃcients and 95% conﬁdence
intervals (95% CIs) were multiplied by loge(2) so that
results represent the mean unit change in outcome per
doubling of 25(OH)D2 or season-adjusted 25(OH)D3.
Coeﬃcients for log-transformed outcomes (triglycer-
ides, insulin and CRP) were expressed in terms of rela-
tive per cent change per doubling of the exposure, by
reformatting ratios of geometric means and 95% CIs.
All regression analyses were conducted using a non-
parametric bootstrap procedure (following 1000 repli-
cations) in conjunction with ordinary least squares
linear regression. The bootstrapping procedure allowed
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us to obtain a valid p-value testing the null hypothesis
that the association of 25(OH)D2 with a given outcome
does not diﬀer from the association of 25(OH)D3 with
this same outcome; these p-values were calculated from
the bootstrap replicate distribution.
We conducted several multivariable linear regression
models for each exposure–outcome association. In
model 1, we adjusted for age and gender. Model 2
was additionally adjusted for potential confounding
by family socioeconomic position and BMI (and
repeated with waist circumference in place of BMI)
measured at the time of 25(OH)D sampling. Because
adiposity tracks across childhood and is strongly asso-
ciated with 25(OH)D and cardiovascular risk factors
we adjusted for both baseline and follow-up (at the
time of cardiovascular risk factor assessment) BMI in
model 2. Lastly, in model 3, we also adjusted for poten-
tial mediation by PTH, circulating calcium and phos-
phate, since vitamin D helps maintain circulating
calcium and phosphate and suppresses production of
PTH, and each of these has been independently asso-
ciated with risk of cardiovascular disease in studies of
adult populations;17–20 and models for 25(OH)D2 also
included adjustment for season-adjusted 25(OH)D3,
and vice versa. Possible non-linearity of associations
between exposures and outcomes was tested by exam-
ining fractional polynomial statistics and interpreting
graphical plots.21
Additional analyses. We conducted multivariable regres-
sion analyses examining mean diﬀerences of cardiovas-
cular risk factors in participants with total 25(OH) D
(the sum of 25(OH)D2 and 25(OH)D3 without seasonal
adjustment) <50 nmol/l and participants with total
25(OH)D between 50 and 72 nmol/l, compared with
risk factors in participants with total 25(OH)D
72 nmol/l.22
We repeated multivariable linear regression analyses
for 25(OH)D3 without adjustment for season of sam-
pling, and also for total 25(OH)D. These models enable
us to observe the eﬀect of seasonality on associations,
and also to compare results with other studies which
have not examined associations of 25(OH)D analogues
with outcomes separately.
Data on physical activity, dietary total energy intake
and pubertal status were available on only 1724
(69.8%) of the 2470 participants included in the main
analyses. Thus, we performed an additional analysis to
determine whether these might confound associations
in this subsample with data on these variables.
We also conducted analyses adjusted for age and
gender including participants who were missing data
on one or more co-variables (and therefore excluded
from main analyses), to see if associations were similar
when these participants were included.
Results
Table 1 shows the characteristics of the study sample
alongside characteristics of those who were eligible but
were excluded from analyses because of missing data
for one or more variable. Children included in the study
had on average higher mean age, waist circumference,
energy intake, PTH, systolic blood pressure (SBP) and
CRP, and were from higher socioeconomic back-
grounds than those excluded because of missing data.
The study sample also had lower mean unadjusted
25(OH)D3, diastolic blood pressure (DBP), triglycer-
ides, low-density lipoprotein cholesterol (LDL-C) and
fasting insulin. In most cases diﬀerences were small in
magnitude.
There was a weak negative correlation between
25(OH)D2 and unadjusted 25(OH)D3 (Pearson’s
r¼0.12, p< 0.001) but not between 25(OH)D2 and
season-adjusted 25(OH)D3 (Pearson’s r¼0.005,
p¼ 0.81). Unadjusted 25(OH)D3 was strongly posi-
tively correlated with both the season-adjusted measure
(Pearson’s r¼ 0.80, p< 0.001) and total 25(OH)D
(Pearson’s r¼ 0.97, p< 0.001). There were weak nega-
tive correlations between PTH and season-adjusted
25(OH)D3 (Pearson’s r¼0.12, p< 0.001) and unad-
justed 25(OH)D3 (Pearson’s r¼0.20, p< 0.001), and
a weak positive correlation between PTH and
25(OH)D2 (Pearson’s r¼ 0.04, p¼ 0.03). Seven hundred
and thirty-six (29.8%) participants had total 25(OH)D
under 50 nmol/l and 1104 (44.7%) participants had
25(OH)D concentrations between 50 and 72 nmol/l.
Table 2 shows the multivariable associations of
childhood 25(OH)D2 with cardiovascular risk factors
measured in adolescence. 25(OH)D2 was not associated
with any cardiovascular risk factors in any of the multi-
variable models.
Table 3 shows the multivariable associations of
season-adjusted 25(OH)D3 and cardiovascular risk fac-
tors. In analyses adjusted for age and gender only
(model 1), 25(OH)D3 was positively associated with
high-density lipoprotein cholesterol (HDL-C) and
inversely associated with fasting insulin. No associ-
ations with other risk factors were observed. Results
remained the same after further adjustments for socio-
economic position and baseline and follow-up BMI
(model 2), and also after adjustments for 25(OH)D2,
PTH, calcium and phosphate (model 3).
There was statistical evidence that associations of
25(OH)D2 with HDL-C and insulin diﬀered from asso-
ciations of 25(OH)D3 with these risk factors in all
models (p for diﬀerences¼ 0.003 for HDL-C; 0.004
for insulin). There was no strong statistical evidence
that associations of 25(OH)D2 and 25(OH)D3 with
other cardiovascular risk factors diﬀered in any model
(all other p 0.27).
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Table 1. Baseline and follow-up characteristics of participants included in the analyses, and of those excluded because of missing data
on one or more variable (mean and standard deviation (SD) unless otherwise stated)
Excluded participants Study sample (n¼ 2470)
n missing Mean (SD) or % Mean (SD) or % p*
Baseline characteristics
Age at 25(OH)D sampling, years 2121 9.8 (1.3) 10.0 (0.9) <0.001
% Male 45.2 49.5 0.001
Clinic of 25(OH) D sampling, %: 2121
7-year follow-up 16.9 4.0
9-year follow-up 66.2 79.6
11-year follow-up 16.9 16.4
Socioeconomic position, % 1626 0.01
I/II 61.6 65.6
III (non-manual work) 24.6 22.4
III (manual work) 9.4 8.7
IV/V 4.4 3.4
BMI (kg/m2) 1989 17.6 (2.9) 17.8 (2.9) 0.10
Waist circ., cm 2100 62.1 (8.1) 63.3 (8.2) <0.001
Recent vigorous physical activity, %a 1569 0.30
None 0.9 0.5
Less than once 4.0 3.6
1–3 times a week 50.3 49.0
4–6 times a week 29.1 31.3
Daily 15.8 15.6
Daily energy intake, kcala 1743 1693.6 (307.0) 1730.9 (307.0) <0.001





b 2121 3.5 (1.2, 7.0) 3.2 (1.2, 6.5) 0.11
25(OH)D3, nmol/l 2121 58.3 (23.4) 56.9 (20.2) 0.01
PTH, pmol/l 2115 4.8 (2.2) 4.9 (2.1) 0.01
Calcium, mmol/l 2112 2.37 (0.11) 2.38 (0.11) 0.71
Phosphate, mmol/l 2095 1.54 (0.16) 1.54 (0.16) 0.33
Measures at follow-up
BMI (kg/m2) 2061 21.4 (3.4) 21.5 (3.7) 0.18
Waist circ., cm 1670 76.7 (9.2) 76.7 (8.6) 0.96
Systolic blood pressure, mmHg 1862 122.7 (10.9) 123.6 (10.7) 0.01
Diastolic blood pressure, mmHg 1862 68.3 (9.1) 66.9 (8.4) <0.001
Triglycerides, mmol/lb 699 0.77 (0.60, 1.01) 0.74 (0.59, 0.97) 0.03
LDL-C, mmol/l 699 2.13 (0.6) 2.07 (0.5) 0.001
HDL-C, mmol/l 699 1.27 (0.28) 1.28 (0.29) 0.83
Glucose, mmol/l 699 5.2 (0.5) 5.2 (0.4) 0.52
Insulin, IU/lb 699 9.4 (6.9, 13.5) 8.9 (6.7, 11.9) <0.001
CRP, mg/lb 699 0.41 (0.23, 1.05) 0.38 (0.22, 0.85) 0.02
aData on physical activity, daily energy intake and pubertal status were available for 1724 participants of our study sample; bMedians (with interquartile
ranges) are shown because of skewed distribution; *p based on two-tailed t-test or chi-square test for differences between groups; 25(OH)D2: 25-
hydroxyvitamin D2; 25(OH)D3: 25-hydroxyvitamin D3; CI: confidence interval; CRP: C-reactive protein; DBP: diastolic blood pressure; HDL-C: high-
density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; SBP: systolic blood pressure.
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There was no strong statistical evidence that any of
the associations of 25(OH)D2 or 25(OH)D3 with out-
comes were non-linear (all p values for deviation from
linearity 0.09).
Table 4 shows mean diﬀerences in cardiovascular
risk factors in those with total 25(OH)D <50 nmol/l
and those with total 25(OH)D between 50 and
72 nmol/l, compared with those with total 25(OH)D
72 nmol/l. Consistent with the linear associations of
25(OH)D3 with outcomes, participants with lower con-
centrations of total 25(OH)D in childhood had lower
HDL-C and higher fasting insulin compared with those
in the high total 25(OH)D group, which remained after
adjustment for potential confounders and mediators.
Participants in the low 25(OH)D groups also had
higher triglycerides compared with those in the high
25(OH)D group.
Supplemental Tables 1 and 2 show multivariable
linear associations of unadjusted 25(OH)D3 and total
25(OH)D with cardiovascular risk factors, respectively.
For both exposures, results were largely the same as
those observed between season-adjusted 25(OH)D3
and cardiovascular risk factors. The one exception
was that inverse associations were present between
both 25(OH)D3 (unadjusted for season) and total
25(OH)D and triglycerides, which remained after
adjusting for potential confounders and mediators. To
further explore why we may have found a positive pro-
spective association of 25(OH)D3 with triglycerides
which is attenuated with seasonal adjustment, we com-
pared the month of the year in which each participant
attended the childhood assessment used for 25(OH)D
sampling with the month in which they attended the
assessment at 15 years. The rationale being that if chil-
dren were called back to clinic at the same time each
year, it is possible that both exposure and outcome are
measured in the same season and that triglyceride levels
are aﬀected by season. However, we found little agree-
ment (6.2%) between the two (compared with 8.6%
agreement expected by chance; Kappa statistic¼0.03;
p¼ 1.0).
Supplemental Tables 3 and 4 show associations of
25(OH)D2 and season-adjusted 25(OH)D3 in the sub-
sample of participants who had data on physical activ-
ity, energy intake and pubertal status at the time of
25(OH)D sampling (n¼ 1724). Results from the sub-
sample were very similar to those of the main analyses,
and adjustment for the additional potential confoun-
ders did not appreciably change associations.
Supplemental Table 5 shows age and gender
adjusted associations of 25(OH)D2 and season-adjusted
25(OH)D3 with cardiovascular risk factors in partici-
pants who formed our main study sample, alongside
associations in samples including participants who
were excluded from main models because of missing
data on one or more co-variable. All associations
were very similar between the samples.
Discussion
In this prospective study, circulating 25(OH)D3 (either
unadjusted or season-adjusted) measured in childhood
was positively associated with HDL-C and inversely
associated with fasting insulin measured in adolescence.
Conversely, circulating 25(OH)D2 was not associated
with any of the cardiovascular risk factors examined.
Children in low total 25(OH)D concentration groups
(<50 nmol/l, or 50 to 72 nmol/l) had lower HDL-C
and higher fasting insulin than those with high concen-
trations (72 nmol/l).
In studies of adult populations, higher total
25(OH)D concentrations or measures of dietary vita-
min D intake have been associated with lower levels
of cardiovascular disease and cardioprotective levels
of cardiovascular risk factors,1,2,14,23 though current
evidence from randomised controlled trials that have
examined these questions and a recent meta-analysis
of them appears to be inconsistent.24–26 With the excep-
tion of our recent cross-sectional study of ALSPAC
children,13 studies examining associations of 25(OH)D
status and cardiovascular risk factors have assessed
total 25(OH)D rather than separate components of
25(OH)D.4,6–8,14 However, since 25(OH)D3 is the
major constituent of circulating 25(OH)D, we would
expect our results for 25(OH)D3 to be comparable to
these previous studies. Thus, the positive prospective
association of 25(OH)D3 (and total 25(OH)D) with
HDL-C reported here is consistent with previous
cross-sectional studies of total 25(OH)D in children
and adolescents.4,7 We also previously observed a posi-
tive, cross-sectional association of 25(OH)D3 with
HDL-C measured in ALSPAC children at mean age
9.9 years.13 The presence of both cross-sectional and
prospective associations of childhood 25(OH)D3 with
HDL-C measured at mean age 9.9 years and again at
15.4 years may in part reﬂect the positive correlation
between HDL-C measures at the two time points
(r¼ 0.60, p< 0.001). However, the prospective associ-
ation observed in the current study remained when
adjusted for childhood HDL-C, suggesting that the
association of 25(OH)D3 with HDL-C is present
throughout childhood and adolescence. If the associ-
ation represents a causal relationship, mechanisms by
which 25(OH)D3 could potentially inﬂuence HDL-C
levels are unclear. VDR-knockout mice (with perturbed
vitamin D receptor function) have a leaner phenotype
than wildtype mice, with reduced circulating triglycer-
ides and total cholesterol,27 but also have lower expres-
sion of Apo-A1mRNA and possibly lower circulating
HDL-C.28 There could potentially be direct or indirect
286 European Journal of Preventive Cardiology 21(3)
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eﬀects of 1,25(OH)2D3 on HDL-C levels, with indirect
eﬀects taking place via eﬀects on intestinal calcium
absorption and/or by decreasing PTH,29 but these
links are speculative.
We also found an inverse association of 25(OH)D3
(and total 25(OH)D) with fasting insulin, which has
been observed previously in children and adolescents,8
although strong associations have not been observed
universally in adolescents following adjustment for adi-
posity measures.4 Our ﬁnding for insulin is in keeping
with prospective studies in adults that have reported
associations of low 25(OH)D status with increased
risk of insulin resistance and type-2 diabetes.2,30
Experimental studies have suggested a direct role of
vitamin D metabolites in improving insulin-mediated
glucose transport, by up-regulating expression of the
human insulin receptor gene,31 and also in the activa-
tion of transcription factors involved in glucose homeo-
stasis.32 There may also be indirect actions of vitamin D
through eﬀects on inﬂammatory processes, or on insu-
lin-mediated intracellular processes via the regulation
of calcium.2,33 However, the lack of association of
25(OH)D3 with fasting glucose in the current study sug-
gests that if there is any inﬂuence of the vitamin D
system on insulin/glucose metabolism, it may not
fully emerge until adulthood.
If higher 25(OH)D3 concentrations are causally
related to lower insulin and higher HDL-C, this could
reﬂect more potent eﬀects of 25(OH)D3 relative to
those of 25(OH)D2 or diﬀerences in the speciﬁc meta-
bolic pathways inﬂuenced by these, via diﬀerent abil-
ities of D3 and D2 metabolites to bind to the vitamin D
receptor, for example.9 Unadjusted 25(OH)D3 and
total 25(OH)D were also inversely associated with tri-
glycerides, in contrast to the null-ﬁnding for season-
adjusted 25(OH)D3. This ﬁnding is also in contrast to
previous cross-sectional studies of children and adoles-
cents, none of which reported associations of total
25(OH)D (or 25(OH)D3)
34 with triglycerides.4,6,7 In
our own previous cross-sectional study using data
from ALSPAC, we found no strong statistical evidence
of associations of either unadjusted and season-
adjusted 25(OH)D3 with triglycerides.
13 Adjustment
of total 25(OH)D or 25(OH)D3 for season provides
an assessment of the individuals’ average status (i.e.
across seasons). It would therefore be expected that
where associations are real, they may be stronger or
the same with seasonal adjustment. Thus, the attenu-
ation of the association of triglycerides with seasonal
adjustment, and a lack of previous evidence for the
association, suggests that the association not adjusted
for season is a chance ﬁnding.
We previously reported positive associations of
25(OH)D2 with inﬂammatory markers (CRP and IL-
6) in the cross-sectional study of ALSPAC children.13
In contrast to those ﬁndings, a lack of prospective asso-
ciation between childhood 25(OH)D2 and CRP mea-
sured in adolescence suggests that childhood
25(OH)D2 concentration is unlikely to be an important
determinant of chronic inﬂammation levels. It therefore
seems possible that the associations previously reported
arose by chance.
Study strengths and limitations
To our knowledge, this is the ﬁrst study to examine
prospective associations of childhood 25(OH)D con-
centration with a broad range of cardiovascular risk
factors in adolescence. It is also the ﬁrst prospective
study to compare the two analogues of 25(OH)D in
relation to these outcomes, which is important in the
consideration of appropriate supplementation, should
further evidence support causality. Moreover, our ana-
lyses were conducted on a non-select general
population.
A limitation of our study is attrition in participant
numbers. However, this is unlikely to have biased
results, as we cannot think of a reason why associations
between 25(OH)D status and cardiovascular risk fac-
tors would diﬀer between included and excluded par-
ticipants. Analogues of 25(OH)D were assessed using
single measures, and so regression dilution of associ-
ations could have occurred, meaning that the associ-
ations presented here may be weaker than any true
association. Total 25(OH)D concentrations have been
shown to correlate over time,35 and our use of a single
measurement is consistent with previous studies in
adults and children of similar associations.4,7,8,14
Conclusion and implications
Based on results from studies in adults, there have been
some calls for policies to recommend higher levels of
safe sun exposure, greater use of vitamin D supplemen-
tation and/or increased fortiﬁcation of foods with the
vitamin in order to prevent cardiovascular dis-
ease.12,36,37 In contrast, others have suggested guide-
lines should not currently be changed for the
purposes of reducing cardiovascular risk because exist-
ing evidence remains inconsistent and insuﬃcient.38
Thus, further prospective studies and randomised con-
trolled trials investigating this are necessary. Current
guidelines about the fortiﬁcation of foods with vitamin
D analogues and the strength/type of vitamin D sup-
plements vary between countries, but where these are
recommended it may not be speciﬁed whether practices
should be based on the use of vitamin D2 or D3.
39 The
ﬁndings from this prospective study – that childhood
25(OH)D3 is associated with higher levels of HDL-C
and lower insulin in adolescence, and that 25(OH)D2 is
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not associated with any risk factors – suggest that
future randomised controlled trials assessing the eﬀect-
iveness of vitamin D supplementation for reducing car-
diovascular risk factors should usefully compare the
beneﬁts of vitamin D3 versus D2 supplementation.
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